Iqbal A, Abbasi ZA, Naeem F. Benefits of six week and personalized dosing of pembrolizumab considering ongoing delta variant surge. J Pak Med Assoc [Internet]. 2022 Feb. 3 [cited 2025 Mar. 25];72(3). Available from: https://jpma.org.pk/index.php/public_html/article/view/4660